Recently, B&K CORPORATION LIMITED (hereinafter referred to as "B&K Corporation") has achieved a new breakthrough. The company's core self-developed bio-ingredient, Thymosin Beta 4 (Tβ4), has successfully passed the rigorous review by the International Nomenclature Committee on Cosmetic Ingredients and received official certification from the Personal Care Products Council (PCPC). It has been officially assigned the INCI name: sh-oligopeptide-4.

This milestone signifies that the Tβ4 ingredient has been formally included in the International Cosmetic Ingredient Dictionary and Handbook and the global wINCI database, granting it an authoritative "international passport" to enter the global cosmetics market. Furthermore, this achievement validates B&K Corporation's full alignment with international standards in R&D, safety evaluation, quality control, and standardization systems. It represents a landmark leap in the company's global compliance strategy for independent bio-ingredients and solidifies the regulatory foundation for its expansion into the global medical aesthetics and raw materials markets.